Do multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy?
Assessment of the number of altered biomarkers in the cystectomy specimen improves the prediction of bladder cancer recurrence and survival in patients with pTa-3N0M0 disease. Prospective evaluation of alteration in these biomarkers can help identify patients who would benefit from adjuvant treatment after radical cystectomy.
Decreased FXII activity may causally relate to reproductive failure.